Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
MorphoSys AG

Start price
Target price
Perf. (%)
€47.81
30.08.21
€53.00
30.08.22
5.67%
04.09.21

Could be worthwhile Investment >10% per year
Innovative
Top 10 in its market
Higher risks for its business
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€20.41
30.08.21
€40.00
31.12.23
-16.71%
07.09.21

Could be very worthwhile Investment >20% year
buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€5.65
30.08.21
€12.00
31.12.23
-66.02%
08.05.23

Could be very worthwhile Investment >20% year
buy
Horizon Pharma plc

Start price
Target price
Perf. (%)
€92.84
30.08.21
€200.00
31.12.23
8.36%
08.05.23

Could be very worthwhile Investment >20% year
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€28.20
30.08.21
€50.00
31.12.23
63.83%
28.06.22

Could be very worthwhile Investment >20% year
buy
Curis Inc.

Start price
Target price
Perf. (%)
€7.08
30.08.21
€30.00
31.12.23
-89.90%
08.05.23

Could be very worthwhile Investment >20% year
buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€43.66
30.08.21
€110.00
31.12.23
-31.75%
08.05.23

Could be very worthwhile Investment >20% year
buy
Chimerix Inc.

Start price
Target price
Perf. (%)
€6.13
30.08.21
€12.00
31.12.23
-83.13%
08.05.23

Could be very worthwhile Investment >20% year
buy
Ocular Therapeutix Inc.

Start price
Target price
Perf. (%)
€9.30
30.08.21
€30.00
31.12.23
-33.87%
22.10.21

Could be very worthwhile Investment >20% year
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€11.70
30.08.21
€30.00
31.12.23
-63.93%
08.05.23

Could be very worthwhile Investment >20% year
Pfizer Inc.

Start price
Target price
Perf. (%)
€39.50
28.08.21
-
28.08.22
0.10%
04.09.21

Risky Investment
buy
Agfa Gevaert N.V.

Start price
Target price
Perf. (%)
€4.44
26.08.21
€5.50
26.08.22
-25.11%
27.08.22

Could be worthwhile Investment >10% per year
buy
Bayer AG

Start price
Target price
Perf. (%)
€47.19
26.08.21
-
26.08.22
5.16%
17.11.21

buy
Edwards Lifesciences Corp.

Start price
Target price
Perf. (%)
€100.15
26.08.21
-
26.08.22
-2.84%
26.08.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€13.84
25.08.21
-
25.08.22
-32.23%
26.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Cara Therapeutics Inc.

Start price
Target price
Perf. (%)
€16.20
24.08.21
-
24.08.22
-24.81%
25.08.21

Probably not worthwhile Investment
buy
Sartorius AG ST

Start price
Target price
Perf. (%)
€629.00
24.08.21
-
24.08.22
-38.00%
24.08.22

buy
Merck KGaA

Start price
Target price
Perf. (%)
€203.40
24.08.21
-
24.08.22
-13.03%
24.08.22

buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€126.20
24.08.21
-
24.08.22
-67.27%
24.08.22

buy
Hexo Corp.

Start price
Target price
Perf. (%)
€31.22
23.08.21
-
23.08.22
-18.39%
14.09.21

Could be worthwhile Investment >10% per year
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€20.42
23.08.21
-
23.08.22
23.56%
14.09.21

Could be very worthwhile Investment >20% year
Innovative
Some uniques
Future proof or reliable business model
buy
Endo International

Start price
Target price
Perf. (%)
€2.07
23.08.21
-
23.08.22
11.85%
14.09.21

Capable Management
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€22.67
23.08.21
€28.00
23.08.22
-0.88%
04.09.21

Could be worthwhile Investment >10% per year
Good culture
Capable Management
Few uniques
buy
CASI Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€12.50
23.08.21
€10.00
23.08.22
7.20%
04.09.21

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Dependend from some customers or products
Evotec SE

Start price
Target price
Perf. (%)
€42.98
23.08.21
-
23.08.22
-7.56%
11.10.21

Risky Investment